RNAMUSE
LIVE

Serial Number

79459734

Owner

arcoris bio AG

Filing Date

Jul 6, 2026

Add to watchlist:

No watchlists yet
View on USPTO

RNAMUSE Trademark

Serial Number: 79459734

RNAMUSE is a trademark filed by arcoris bio AG on July 6, 2026. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

arcoris bio AG (4 trademarks)

Wagistrasse 25

Entity Type: 33

Trademark Details

Filing Date

July 6, 2026

Registration Date

Not Registered

Goods & Services

Scientific and technological services as well as research and design services relating thereto; industrial analysis, industrial research and industrial design services; quality control; research and development in the field of diagnostic preparations; temporary online provision of applications and software tools; scientific research; advice in connection with science; scientific research and development; scientific research services for medical purposes.

Chemical products for use in industry, science and photography; biological preparations for use in industry and science; biochemical products for in-vitro and in-vivo scientific use; reagents for research; diagnostic preparations for use in research laboratories; chemical preparation for marking biomolecules comprising reagents intended for scientific research.

In-vitro diagnostic preparations for medical use; reagents for medical use; chemical reagents for medical use; diagnostic reagents for medical use; chemical diagnostic reagents for medical use; diagnostic biomarking reagents for medical use; diagnostic kits comprising diagnostic reagents for medical use; analytical reagents for medical use; immunological reagents for medical use; reagents for genetic testing in medicine.

Filing History

ASSIGNED TO EXAMINER
Oct 5, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 1, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 1, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 1, 2026 REPR